PRPH2 Gene Fundus albipunctatus Genetic Test sale cost 4400 AED
CACNA1F Gene Cone-rod dystrophy X-linked type 3 Genetic Test sale cost 4400 AED CACNA1F Gene Cone-rod dystrophy X-linked type 3 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Leber's Hereditary Optic Neuropathy LHON Mitochondrial Mutation Detection Test sale cost 1290 AED Leber's Hereditary Optic Neuropathy LHON Mitochondrial Mutation Detection Test 1,430 د.إ Original price was: 1,430 د.إ.1,290 د.إCurrent price is: 1,290 د.إ.
Sale!

PRPH2 Gene Fundus albipunctatus Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PRPH2 Gene Fundus Albipunctatus Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the PRPH2 gene, which are linked to Fundus Albipunctatus, a rare genetic disorder. This condition is characterized by the presence of numerous small, white or yellow dots scattered across the retina, which can lead to night blindness or delayed dark adaptation, although vision is usually otherwise normal. The test is crucial for accurate diagnosis, enabling targeted management and genetic counseling for affected individuals and their families. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the PRPH2 gene and provide a comprehensive understanding of the genetic basis of Fundus Albipunctatus. Conducted in the advanced facilities of DNA Labs UAE, this test represents a significant step forward in the personalized care and management of patients with this rare retinal disorder.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PRPH2 Gene Fundus albipunctatus Genetic Test

Components:

  • Test Name: PRPH2 Gene Fundus albipunctatus Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ophthalmology Disorders
  • Doctor: Ophthalmologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for PRPH2 Gene Fundus albipunctatus NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRPH2 Gene Fundus albipunctatus NGS Genetic DNA Test gene PRPH2.

Test Details:

The PRPH2 gene is associated with Fundus albipunctatus, a rare genetic disorder that affects the retina of the eye. This condition is characterized by the presence of white or yellow spots on the retina, which can cause vision problems such as reduced visual acuity and night blindness.

NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool that can identify mutations in the PRPH2 gene. This test involves sequencing the entire coding region of the gene to detect any changes or abnormalities that may be causing the disease. NGS testing can provide a definitive diagnosis of Fundus albipunctatus and can help guide treatment and management strategies. It can also be used for genetic counseling and to identify family members who may be at risk for the condition.

Overall, NGS genetic testing for the PRPH2 gene is an important tool for the diagnosis and management of Fundus albipunctatus.

Test Name PRPH2 Gene Fundus albipunctatus Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PRPH2 Gene Fundus albipunctatus NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRPH2 Gene Fundus albipunctatus NGS Genetic DNA Test gene PRPH2
Test Details

The PRPH2 gene is associated with Fundus albipunctatus, a rare genetic disorder that affects the retina of the eye. This condition is characterized by the presence of white or yellow spots on the retina, which can cause vision problems such as reduced visual acuity and night blindness.

NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool that can identify mutations in the PRPH2 gene. This test involves sequencing the entire coding region of the gene to detect any changes or abnormalities that may be causing the disease.

NGS testing can provide a definitive diagnosis of Fundus albipunctatus and can help guide treatment and management strategies. It can also be used for genetic counseling and to identify family members who may be at risk for the condition.

Overall, NGS genetic testing for the PRPH2 gene is an important tool for the diagnosis and management of Fundus albipunctatus.

SKU: TEST-993 Category:

Related products